Earnings call: TELA Bio reports robust Q4 growth, optimistic 2024 outlook By Investing.com
[ad_1] © Reuters. TELA Bio, Inc. (NASDAQ:) has announced its financial results for the fourth quarter and the full year of 2023, demonstrating significant revenue...
Gossamer Bio EVP sells over $5,000 in company stock By Investing.com
[ad_1] © Reuters. Gossamer Bio, Inc.’s (NASDAQ:) Executive Vice President of Regulatory Affairs, Caryn Peterson, has recently sold a portion of her company shares, according...
Graphite Bio announces $1.03 per share special dividend By Investing.com
[ad_1] © Reuters. SOUTH SAN FRANCISCO, Calif. – Graphite Bio, Inc. (NASDAQ:GRPH), a clinical-stage gene editing company, has declared a special dividend of approximately $1.03...
Korro Bio shares climb on BMO’s Outperform rating, $120 target By Investing.com
[ad_1] © Reuters. Tuesday – Korro Bio Inc. (NASDAQ:KRRO) received an Outperform rating from BMO Capital Markets, accompanied by a price target of $120. The...
GSK completes acquisition of Aiolos Bio for up to $1.4 billion By Reuters
[ad_1] © Reuters. FILE PHOTO: GSK (GlaxoSmithKline) logo is seen in this illustration, August 10, 2022. REUTERS/Dado Ruvic/Illustration/File Photo LONDON (Reuters) – GSK said on...